A detailed history of Manchester Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Manchester Capital Management LLC holds 79 shares of DXCM stock, worth $8,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Previous 62 27.42%
Holding current value
$8,957
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$114.22 - $140.1 $1,941 - $2,381
17 Added 27.42%
79 $10,000
Q4 2023

Feb 08, 2024

BUY
$75.49 - $124.16 $4,076 - $6,704
54 Added 675.0%
62 $7,000
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $899 - $1,047
8 New
8 $1,000
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $254 - $314
-3 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $234 - $313
3 New
3 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.